Please wait while the formulary information is being retrieved.
VITAJOY (MELATONIN)
2.5 mg chewable tablet
- Dosage information is not available
2.5 mg chewable tablet
- Dosage information is not available
5 mg chewable tablet
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Autoimmune disease
- Systemic lupus erythematosus
Severe
Moderate
- None
VITAJOY (MELATONIN)
- None
- Dizziness
- Headache disorder
- Sedation hangover effect
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Acute confusion
- CNS depression
- Concentration difficulty
- Depression
- Hypotension
- Irritability
- Nausea
- Symptoms of anxiety
- Tremor
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Panic disorder
Contraindicated
None
Severe Precaution
Melatonin
Rare reports of neurological adverse events including anxiety, panic reaction, visual hallucination and seizure, Consult clinician prior to use.
- 1 Day – 18 Years
- Rare reports of neurological adverse events including anxiety, panic reaction, visual hallucination and seizure, Consult clinician prior to use.
Management or Monitoring Precaution
None
Melatonin
- Severity Level:
2
- Additional Notes: Insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Melatonin
Insufficient data available; may affect prolactin levels
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; may affect prolactin levels |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool